Potts indicated to Daily Racing Form he will appeal the ruling – which set the suspension dates from Sept. 1-15, inclusive – adding that he would likely wind up serving the suspension at the beginning of the 2022 meet. Potts was also assigned a half point under the multiple medication violation (MMV) program.

Kentucky Cool won the second race at Monmouth for Potts and owner Bruno Schickedanz on June 5 and was subsequently found by Industrial Laboratories of Wheat Ridge, Colo., to have flunixin at 10.1 nanograms per milliliter in his blood sample, twice the amount permitted.

Potts told Daily Racing Form that Kentucky Cool may have inadvertently received two doses of flunixin – one at Belmont Park, where he was stabled, and another at Monmouth Park after arriving there two days before the race.

Potts, with 24 wins from 93 starts at Monmouth Park this year, was most recently sanctioned for a medication violation in 2019.

Kentucky Cool was disqualified from the June 5 race with the $13,200 purse money he earned redistributed. He was claimed from that race by owner-trainer Anthony Foglia and has subsequently finished fifth (of five runners), 10th (of 10), eighth (of 9) and third (of nine).

The post Potts Suspended 15-Days For New Jersey Medication Violation appeared first on Horse Racing News | Paulick Report.

Source of original post